L
1457
Merck, the German pharmaceutical group, announced the acquisition of the British biotechnology company Silence Therapeutics for approximately 980 million euros, a transaction that is expected to be finalized in the first quarter of 2027. #Merck #SilenceTherapeutics #Biotechnologie (translated)
www.lesoir.be
Merck rachète une biotech britannique pour près d'un milliard d'euros
